HIGHLIGHTS
- who: from the SARS-Co, variants resistant to monoclonal antibodies in immunocompromised patients constitute a public health concern Arturo Casadevall, and Daniele Focosi, Department of Molecular Microbiology and Immunology, Johns Hopkins Bloomberg School of Public Health, Baltimore, Maryland, USA North-Western Tuscany Blood Bank, Pisa University Hospital, Pisa, Italy. have published the research: SARS-CoV-2 variants resistant to monoclonal antibodies in immunocompromised patients constitute a public health concern, in the Journal: (JOURNAL)
SUMMARY
The Journal of Clinical Investigation SARS-CoV-2_variants resistant to monoclonal_antibodies in immunocompromised patients constitute a public health concern . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.